ClinicalTrials.gov record
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
ClinicalTrials.gov ID: NCT01735630
Public ClinicalTrials.gov record NCT01735630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 5, 2026, 12:04 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Efficacy and Safety Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer's Disease
Study identification
- NCT ID
- NCT01735630
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- OPKO Health, Inc.
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- ELND005 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012
- Primary completion
- Apr 30, 2015
- Completion
- Apr 30, 2015
- Last update posted
- Oct 20, 2019
2012 – 2015
United States locations
- U.S. sites
- 57
- U.S. states
- 25
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TransitionTIL Investigational Site | Birmingham | Alabama | 35294 | — |
| TransitionTIL Investigational Site | Phoenix | Arizona | 85004 | — |
| TransitionTIL Investigational Site | Phoenix | Arizona | 85006 | — |
| TransitionTIL Investigational Site | Encino | California | 91316 | — |
| TransitionTIL Investigational Site | Escondido | California | 92025 | — |
| TransitionTIL Investigational Site | Fresno | California | 93710 | — |
| TransitionTIL Investigational Site | Irvine | California | 92697 | — |
| TransitionTIL Investigational Site | Long Beach | California | 90806 | — |
| TransitionTIL Investigational Site | Los Alamitos | California | 90720 | — |
| TransitionTIL Investigational Site | Los Angeles | California | 90073 | — |
| TransitionTIL Investigational Site | Newport Beach | California | 92663 | — |
| TransitionTIL Investigational Site | Santa Ana | California | 92701 | — |
| TransitionTIL Investigational Site | Norwalk | Connecticut | 06851 | — |
| TransitionTIL Investigational Site | Washington D.C. | District of Columbia | 20057 | — |
| TransitionTIL Investigational Site | Atlantis | Florida | 33462 | — |
| TransitionTIL Investigational Site | Deerfield Beach | Florida | 33064 | — |
| TransitionTIL Investigational Site | Delray Beach | Florida | 33445 | — |
| TransitionTIL Investigational Site | Lake Worth | Florida | 33449 | — |
| TransitionTIL Investigational Site | Miami | Florida | 33137 | — |
| TransitionTIL Investigational Site | Oakland Park | Florida | 33334 | — |
| TransitionTIL Investigational Site | Orlando | Florida | 32806 | — |
| TransitionTIL Investigational Site | Ormond Beach | Florida | 32174 | — |
| TransitionTIL Investigational Site | Port Charlotte | Florida | 33952 | — |
| TransitionTIL Investigational Site | Sarasota | Florida | 34243 | — |
| TransitionTIL Investigational Site | Sunrise | Florida | 33351 | — |
| TransitionTIL Investigational Site | Columbus | Georgia | 31909 | — |
| TransitionTIL Investigational Site | Savannah | Georgia | 31419 | — |
| TransitionTIL Investigational Site | Springfield | Illinois | 62702 | — |
| TransitionTIL Investigational Site | Bangor | Maine | 04402 | — |
| TransitionTIL Investigational Site | Easton | Maryland | 21601 | — |
| TransitionTIL Investigational Site | Winchester | Massachusetts | 01890 | — |
| TransitionTIL Investigational Site | Ann Arbor | Michigan | 48105 | — |
| TransitionTIL Investigational Site | Paw Paw | Michigan | 49079 | — |
| TransitionTIL Investigational Site | Saint Paul | Minnesota | 55130 | — |
| TransitionTIL Investigational Site | Hattiesburg | Mississippi | 39401 | — |
| TransitionTIL Investigational Site | Stratford | New Jersey | 08084 | — |
| TransitionTIL Investigational Site | Rochester | New York | 14620 | — |
| TransitionTIL Investigational Site | Rochester | New York | 14623 | — |
| TransitionTIL Investigational Site | Charlotte | North Carolina | 28209 | — |
| TransitionTIL Investigational Site | Charlotte | North Carolina | 28211 | — |
| TransitionTIL Investigational Site | Durham | North Carolina | 27710 | — |
| TransitionTIL Investigational Site | Wilmington | North Carolina | 28401 | — |
| TransitionTIL Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| TransitionTIL Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| TransitionTIL Investigational Site | Portland | Oregon | 97225 | — |
| TransitionTIL Investigational Site | Abington | Pennsylvania | 19001 | — |
| TransitionTIL Investigational Site | Jenkintown | Pennsylvania | 19046 | — |
| TransitionTIL Investigational Site | Norristown | Pennsylvania | 19401 | — |
| TransitionTIL Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| TransitionTIL Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| TransitionTIL Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| TransitionTIL Investigational Site | North Charleston | South Carolina | 29406 | — |
| TransitionTIL Investigational Site | Port Royal | South Carolina | 29935 | — |
| TransitionTIL Investigational Site | Nashville | Tennessee | 37212 | — |
| TransitionTIL Investigational Site | DeSoto | Texas | 75115 | — |
| TransitionTIL Investigational Site | Richmond | Virginia | 23230 | — |
| TransitionTIL Investigational Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01735630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2019 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01735630 live on ClinicalTrials.gov.